prognostic signature Nov 18, 2020 Agendia, Paige Partner to Codevelop New Assays Using MammaPrint, BluePrint Signatures Nov 22, 2019 Racial Group Comparison Suggests More Research Needed on Prostate Cancer Recurrence Tests Premium May 21, 2019 Biotech Support Group, Leiden University Medical Center Ink Cancer Biomarker Research Agreement Feb 22, 2019 Expression-Based Survival Signature Proposed for Glioblastoma Jun 14, 2018 Breast, Lung Cancer Genetics Highlight Mutations Linked to Drug Response, Prognosis Jun 3, 2018 Fewer Breast Cancer Patients Benefit From Chemo, TAILORx Study With Oncotype DX Finds Jul 19, 2017 Circulating Tumor DNA Dynamics May Hold Hints to Immunotherapy Response, Pseudoprogression Jul 10, 2017 ASCO Guideline Update Recommends Agendia MammaPrint in 1-3-Node Patients Breaking News Apollomics Completes SPAC Merger, Begins Public Trading on Nasdaq Ablaze Pharmaceuticals to Develop RayzeBio's GPC3-Targeted Radiotherapy In Brief This Week: Allarity Therapeutics, Immutep, Thermo Fisher Scientific EMA's CHMP Recommends BMS's Breyanzi as Second-Line Lymphoma Treatment Exai Bio, Quantum Leap Healthcare Collaborative Expand Participation in RNA Liquid Biopsy Trial Omega Therapeutics, Roche Partner for Phase I/II Trial in MYC-Driven Hepatocellular Carcinoma
